BerGenBio presents positive preclinical data on BGB324
21 September 2015 | By Victoria White
The data highlights that BGB324 used in combination with immune checkpoint inhibitors in mouse carcinoma models showed enhanced tumour clearance compared with checkpoint inhibition alone...